Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,004.16 -3.57 (-0.35%)

Streaming Delayed Price Updated: 1:27 PM EST, Mar 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients ↗

February 17, 2026

Eli Lilly's lung cancer trial shows lower recurrence risk and strong survival benefit in early-stage patients.

Via Benzinga

Eli Lilly & Co (NYSE:LLY) Combines Explosive Growth with a Bullish Technical Setup ↗

February 17, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Lower As AI Disruption Fears Linger: Why AAPL, ZIM, OCUL, NCLH Are On Traders' Radar Today ↗

February 17, 2026

Wall Street resumed trade after the Presidents’ Day break to find a market still grappling with the ‘AI disruption’ trade.

Via Stocktwits

Novo Nordisk's New Diabetes Drug Outshines Ozempic: Is The Stock a Buy? ↗

February 16, 2026

Novo Nordisk's plan to gain ground in the GLP-1 space is slowly taking shape.

Via The Motley Fool

Liberty One Cuts Its Lamb Weston Position in Half With $32 Million Sale ↗

February 16, 2026

Lamb Weston is a global leader in frozen potato products, serving both retail and foodservice markets with a diversified brand portfolio.

Via The Motley Fool

Topics Economy Regulatory Compliance Supply Chain

Forget AI Stocks: This Pharma Giant Is Using AI to Dominate Drug Discovery ↗

February 15, 2026

And there's more than one way to monetize this technology.

Via The Motley Fool

Topics Artificial Intelligence

The Smartest Growth ETF to Buy With $1,000 Right Now. (Hint: It Has Averaged Annual Gains of 18.6% Over the Past 10 Years.) ↗

February 15, 2026

It's an easy way to quickly own 150-plus companies growing at a solid clip.

Via The Motley Fool

Topics ETFs

Eli Lilly Just Delivered Great News for Investors -- and It Goes Beyond Weight-Loss Drugs ↗

February 15, 2026

Eli Lilly isn't a one-trick pony.

Via The Motley Fool

What Is One of the Best Pharmaceutical Stocks to Own for the Next 10 Years? ↗

February 14, 2026

Eli Lilly continues to pursue smart acquisitions for the long term.

Via The Motley Fool

Topics Intellectual Property

Got $500? 2 Pharma Stocks to Buy and Hold Forever. ↗

February 14, 2026

Growth, value, or both?

Via The Motley Fool

Novo Nordisk To Meet Wegovy Pill Demand In US Before Expanding To Avoid Supply Shortage, Says CEO Doustdar ↗

February 13, 2026

Novo is looking to ensure the U.S. market is supplied before choosing another country to scale in, Doustdar said in an interview with CNBC.

Via Stocktwits

Topics Lawsuit

"Blowout" Jobs Report Ignites 2026 Growth Hopes as Unemployment Hits 4.3% Floor

February 13, 2026

The U.S. labor market kicked off 2026 with an unexpected surge, as the January nonfarm payrolls report shattered analyst expectations and provided a much-needed jolt to the economic outlook. Adding...

Via MarketMinute

Topics Artificial Intelligence Economy Workforce

Hospitals Stand Tall: Healthcare Sector Becomes Safe Haven Amid "Warsh Shock" and Tech Volatility

February 13, 2026

In a day defined by sharp reversals and a fundamental recalibration of market leadership, the healthcare sector emerged as the primary beneficiary of a massive capital rotation on February 13, 2026....

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug? ↗

February 13, 2026

Eli Lilly announced an acquisition of an innovative new autoimmune drug.

Via The Motley Fool

The Great 2026 Divergence: Tech Titans Rise on AI Execution While Healthcare Reaps a Regulatory Whirlwind

February 13, 2026

As the opening bell rang on February 13, 2026, the divergence between the U.S. technology and healthcare sectors reached a historic fever pitch, signaling a fundamental shift in how markets price...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Meet the 6.3% Yield Dividend Stock That Could Soar in 2026 ↗

February 13, 2026

Pfizer's long-acting GLP-1 weight loss candidate could set the stage for a stock rally.

Via The Motley Fool

Topics Intellectual Property

Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms ↗

February 13, 2026

Eli Lilly and Company (NYSE: LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulatory filing on Thursday.

Via Benzinga

Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI Data: Why NVDA, AAPL, TSLA, RIVN, MRNA, AMAT, IREN Are On Traders' Radar Today ↗

February 13, 2026

Data on Stocktwits showed retail traders remained bearish on SPY and ‘extremely bearish’ on QQQ.

Via Stocktwits

Topics Bonds ETFs Economy

Meta Platforms Breaks Ground on Massive $10 Billion Indiana Data Center: A Giant Leap Toward 'Personal Superintelligence'

February 12, 2026

On February 11, 2026, Meta Platforms Inc. (NASDAQ: META) officially broke ground on a sprawling $10 billion data center campus in Lebanon, Indiana, marking a monumental shift in the company’s...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026

February 12, 2026

As of February 12, 2026, the financial landscape has undergone a tectonic shift, with the healthcare sector decisively seizing the mantle of market leadership. After years of dominance by high-flying...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market ↗

February 12, 2026

Novo Nordisk plans to sell Wegovy in vials in the U.S., expanding options as it competes with Eli Lilly in the growing weight-loss drug market.

Via Benzinga

Healthcare’s Renaissance: Sector Outshines Tech as Policy Clarity Sparks Q4 Surge

February 12, 2026

The healthcare sector has staged a dramatic structural breakout, ending a multi-year period of relative stagnation to lead the global markets into 2026. After a powerful 10% gain in the final quarter...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

Goldman Sachs Predicts 12% S&P 500 Rally in 2026: Five Key Themes for the "Marathon" Bull Market

February 12, 2026

As the global economy stabilizes into a period of disinflationary growth, Goldman Sachs (NYSE: GS) has released a robust 2026 stock market outlook, forecasting a 12% total return for the S&P 500. This...

Via MarketMinute

Topics Artificial Intelligence Economy Initial Public Offering

Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know. ↗

February 12, 2026

Both companies are betting on interest in weight loss pills.

Via The Motley Fool

1 Cash-Producing Stock with Competitive Advantages and 2 That Underwhelm

February 11, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

I Predicted That ExxonMobil Would Join the $1 Trillion Club by 2030, But the Stock Is Already Up 24% in 2026. Is the High-Yield Dividend Stock Still a Buy Now? ↗

February 11, 2026

Energy stocks are in the spotlight, and ExxonMobil is best in breed.

Via The Motley Fool

Topics Artificial Intelligence

VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline ↗

February 11, 2026

The company shared optimistic timelines for advancing the clinical studies of both oral and subcutaneous VK2735 in obesity.

Via Stocktwits

Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly ↗

February 11, 2026

Bloomberg reported on Wednesday, citing Novo CEO Mike Doustdar, that the vials are slated to be introduced in the U.S. this year.

Via Stocktwits

Topics Intellectual Property

3 Reasons to Buy Eli Lilly Stock ↗

February 11, 2026

The healthcare leader looks increasingly unstoppable.

Via The Motley Fool

Topics Government

Disney Has Its Next CEO ↗

February 11, 2026

Disney has hired a new CEO, with Josh D'Amaro taking over for Bob Iger in March.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.